Therefore, future studies need to incorporate detailed neuroinflammatory profiling to evaluate BoNT-mediated effects, including changes in TNF-α, IL-1β, and IL-6 expression, either in the brain or under in vivo and in vitro conditions using different PD models and cell lines of neuronal and non-neuronal origins. The gene discussed is TNF; the disease is Parkinson disease.